Follow-The-Filings

Security

NBIX

Neurocrine Biosciences Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

14 owners 1 new 1 exit max 0.5% (Renaissance Technologies LLC)

grid → activity →
owners 14
max % 0.5%
tracked value $3.7B
qoq N 1 A 7 R 4 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.5% Add +0.01 pp 2,418,897 $319M hist
Dodge & Cox 2026 Q1 0.4% Reduce -0.03 pp 5,461,037 $719M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.3% Add +0.06 pp 4,938,967 $651M hist
Two Sigma Investments, LP 2025 Q4 stale 0.2% Exit -0.20 pp 984,811 $140M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.2% Add +0.06 pp 360,136 $47M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.1% Reduce +0.01 pp 148,141 $20M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.1% Add +0.04 pp 1,247,447 $164M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.1% Add +0.02 pp 508,977 $67M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 9,700,301 $1.4B hist
Norges Bank 2025 Q4 stale 0.0% Exit -0.02 pp 1,146,896 $163M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 122,226 $16M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% New 0.0% 89,184 $12M hist
Natixis Advisors, LLC 2026 Q1 0.0% Add 0.00 pp 43,597 $6M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 57,968 $8M hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.03 pp 141,101 $20M hist

14 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.89B $2.36B $2.86B
Gross profit * $1.85B $2.32B $2.81B
Gross margin * 97.9% 98.6% 98.2%
Net income $249.7M $341.3M $478.6M
Net margin * 13.2% 14.5% 16.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.61B $1.72B $2.52B
Total non-current assets * $1.64B $1.99B $2.11B
Total assets $3.25B $3.72B $4.63B
Total current liabilities $654.8M $507.7M $743.4M
Total non-current liabilities * $364.6M $621.3M $635M
Total equity $2.23B $2.59B $3.25B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $389.9M $595.4M $782.7M
Cash from investing -$467.1M -$126.8M -$264.4M
Cash from financing $65.3M -$486.7M -$38.3M
Net change in cash -$11.6M -$18.1M $480M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders